AstraZeneca to invest £330 Million in new strategic R&D centre and global headquarters in Cambridge

AstraZeneca to invest £330 Million in new strategic R&D centre and global headquarters in Cambridge

[at noodls] – AstraZeneca today announced its intention to establish a new global R&D centre and corporate headquarters in Cambridge in the UK by 2016. The planned investment of around £330 million ($500 million) to … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view

Share this post